Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;37(5):431-439.
doi: 10.14670/HH-18-421. Epub 2021 Jan 18.

Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery

Mustafa A Maher  1 , Wafaa A Kandeel  2 , Olfat A Hammam  3 , Yasmeen M Attia  4 , Soheir Mahmoud  5 , Mohamed Salah  6
Affiliations

Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery

Mustafa A Maher et al. Histol Histopathol. 2022 May.

Abstract

The combination of insulin and DMSO is a patented (Publication No US8987199B2), noninvasive, pharmaceutically strategized preparation for direct nose-to-brain delivery (DN2BD) suggested for the treatment of Alzheimer's disease (AD). Although its main ingredients have been individually researched, no histopathological investigations have been conducted to address this combination effect on the CNS and nasal tissues in animals. The present work was, therefore, designed to investigate the potential histopathological changes induced by this new pharmaceutical combination using a newly developed refractory staining method. The findings presented herein showed no signs of treatment-related lesions or behavioral changes in Sprague Dawley rats following a three-month successive treatment with two strengths of the formula.

PubMed Disclaimer

References

    1. Abhyankar M.M., Noor Z., Tomai M.A., Elvecrog J., Fox C.B. and Petri W.A. Jr (2017). Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica. Vaccine 35, 916-922. - PMC - PubMed
    1. Alexander A. and Saraf S. (2018). Nose-to-brain drug delivery approach: A key to easily accessing the brain for the treatment of Alzheimer’s disease. Neural Regen. Res. 13, 2102-2104. - PMC - PubMed
    1. Alturkistani H.A., Tashkandi F.M. and Mohammedsaleh Z.M. (2015). Histological stains: A literature review and case study. Glob. J. Health Sci. 8, 72-79. - PMC - PubMed
    1. Avgerinos K.I., Kalaitzidis G., Malli A., Kalaitzoglou D., Myserlis P.G. and Lioutas V.A. (2018). Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review. J. Neurol. 265, 1497-1510. - PMC - PubMed
    1. Bourganis V., Kammona O., Alexopoulos A. and Kiparissides C. (2018). Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. Eur. J. Pharm. Biopharm. 128, 337-362. - PubMed

LinkOut - more resources